Laurence Colin | Disease Area Scientific Lead Statistician for Autoimmunity in Early Development
Novartis

Laurence Colin, Disease Area Scientific Lead Statistician for Autoimmunity in Early Development, Novartis

- I have an MSc in Mathematics from the University of Liege, Belgium, and a Masters in Biostatistics from the University of Hasselt, Belgium - I have been working as a statistician at Novartis since 2006, where I first supported phase III and IV trials. I am currently working in the Translational Sciences group where I support the design aspects of Phase II trials for several projects

Share this

Appearances at this years' conference:

Wednesday 23 May 2012- Accelerating early development stream


@ 15.45
Objective comparison of early clinical development plans and better PoC decision-making

  • › Laurence Colin, Disease Area Scientific Lead Statistician for Autoimmunity in Early Development, Novartis
Sponsors
Sponsors
Aptiv Solutions at Exploratory Clinical Development World Europe
Sponsors
CoreLab Partners at Exploratory Clinical Development World Europe
Sponsors
Optimed at Exploratory Clinical Development World Europe
Sponsors
Xceleron at Exploratory Clinical Development World Europe
Sponsors
iCardiac Technologies at Exploratory Clinical Development World Europe
Sponsors
PRA International at Exploratory Clinical Development World Europe